Hikaru Sasaki

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 12

Top Topics

Top Venues

Brain tumor pathology

Journal of neuro-oncology

Neurosurgical review

This page only lists publications with an associated author ORCID identifier.

Publications

Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology (2024)
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology 41 (2) (2024)
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology 41 (2) (2024)
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology 41 (2) (2024)
Ryota Tamura, Akio Iwanami, Kentaro Ohara, Masaaki Nishimoto, Eriel Sandika Pareira, Tomoru Miwa, Naoko Tsuzaki, Yuki Kuranari, Yukina Morimoto, Masahiro Toda, Hideyuki Okano, Masaya Nakamura, Kazunari Yoshida, Hikaru Sasaki
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain tumor pathology (2023)
Eriel Sandika Pareira, Makoto Shibuya, Kentaro Ohara, Yu Nakagawa, Tokunori Kanazawa, Dai Kamamoto, Yasutaka Kato, Eri Arai, Eriko Aimono, Kazunari Yoshida, Hiroshi Nishihara, Yae Kanai, Hikaru Sasaki
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas. Brain tumor pathology 39 (2) (2022)
Tokunori Kanazawa, Kentaro Ohara, Yohei Kitamura, Masato Nakaya, Kazunari Yoshida, Hikaru Sasaki
Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy. Journal of neuro-oncology 155 (3) (2021)
Tokunori Kanazawa, Yasuhiro Minami, Hidenori Takahashi, Hirokazu Fujiwara, Masahiro Toda, Masahiro Jinzaki, Kazunari Yoshida, Hikaru Sasaki
Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion. Neurosurgical review 43 (4) (2019)
Masaaki Nishimoto, Kentaro Ohara, Dai Kamamoto, Ryota Tamura, Tomoru Miwa, Kazunari Yoshida, Hikaru Sasaki
Tumor immune microenvironment is associated with the growth of intracranial germinomas. Journal of neuro-oncology 146 (1) (2019)
Dai Kamamoto, Kentaro Ohara, Yohei Kitamura, Kazunari Yoshida, Yutaka Kawakami, Hikaru Sasaki
Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma. Journal of neuro-oncology 139 (2) (2018)
Ryota Tamura, Toshihide Tanaka, Kentaro Ohara, Keisuke Miyake, Yukina Morimoto, Yohei Yamamoto, Ryuichi Kanai, Yasuharu Akasaki, Yuichi Murayama, Takashi Tamiya, Kazunari Yoshida, Hikaru Sasaki
Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab. Cancer science 110 (2) (2018)
Saeko Hayashi, Yohei Kitamura, Yuichi Hirose, Kazunari Yoshida, Hikaru Sasaki
Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis. Journal of neuro-oncology 132 (1) (2016)